Relaxin Physiology in the Female Reproductive Tract during Pregnancy

Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 612)


The characteristic functions of relaxin are associated with female reproductive tract physiology. These include the regulation of biochemical processes involved in remodeling the extracellular matrix of the cervix and vagina during pregnancy and rupture of the fetal membranes at term. Such modifications enable the young to move unimpeded through the birth canal and prevent dystocia. However, relaxin’s physiological actions are not limited to late gestation. New functions for this peptide hormone in implantation and placentation are also emerging. Relaxin promotes uterine and placental growth and influences vascular development and proliferation in the endometrium. This chapter provides an overview of the current literature on relaxin physiology in the uterus, cervix and vagina of pregnant females and the impact on fetal health. It also outlines the potential mechanisms of relaxin action, particularly in the cervical extracellular matrix and uterine endometrium.


Uterine Artery Endometrial Stromal Cell Uterine Blood Flow Human Endometrial Stromal Cell LGR7 Expression 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Hisaw FL. Experimental relaxation of the pubic ligament of the guinea pig. Proc Soc Exp Biol Med 1926; 23:661–663.Google Scholar
  2. 2.
    Sherwood OD. Relaxin’s physiological roles and other diverse actions. Endocr Rev 2004; 25(2):205–234.PubMedCrossRefGoogle Scholar
  3. 3.
    Guico-Lamm ML, Voss EWJ, Sherwood OD. Monoclonal antibodies specific for rat relaxin. II. Passive immunization with monoclonal antibodies throughout the second half of pregnancy disrupts birth in intact rats. Endocrinology 1988; 123(5):2479–2485.PubMedGoogle Scholar
  4. 4.
    Hwang JJ, Sherwood OD. Monoclonal antibodies specific for rat relaxin. III. Passive immunization with monoclonal antibodies throughout the second half of pregnancy reduces cervical growth and extensibility in intact rats. Endocrinology 1988; 123(5):2486–2490.PubMedGoogle Scholar
  5. 5.
    Kuenzi MJ, Sherwood OD. Monoclonal antibodies specific for rat relaxin. VII. Passive immunization with monoclonal antibodies throughout the second half of pregnancy prevents development of normal mammary nipples morphology and function in rats. Endocrinology 1992; 131(4):1841–1847.PubMedCrossRefGoogle Scholar
  6. 6.
    Zhao L, Roche PJ, Gunnerson JM et al. Mice without a functional relaxin gene are unable to deliver milk to their pups. Endocrinology 1999; 140(1):445–453.PubMedCrossRefGoogle Scholar
  7. 7.
    Weiss G, Palejwala S, Tseng L et al. Synthesis and function of relaxin in human endometrium. In: Tregear GW, Ivell R, Bathgate RA, Wade JD, eds. Relaxin 2000. Dordrecht, The Netherlands: Kluwer Academic Publishers, 2001:41–45.Google Scholar
  8. 8.
    Hayes ES. Biology of primate relaxin: a paracrine signal in early pregnancy? Reprod Biol Endocrinol 2004; 2:36.PubMedCrossRefGoogle Scholar
  9. 9.
    Hsu SY, Nakabayashi K, Nishi S et al. Activation of orphan receptors by the hormone relaxin. Science 2002; 295:671–674.PubMedCrossRefGoogle Scholar
  10. 10.
    Hsu SYT. New insights into the evolution of the relaxin-LGR signalling system. Trends Endocrin Met 2003; 14(7):303–309.CrossRefGoogle Scholar
  11. 11.
    Scott DJ, Layfield S, Riesewijk A et al. Identification and characterization of the mouse and rat relaxin receptors as the novel orthologues of human leucine-rich repeat-containing G-protein-coupled receptor 7. Clin Exp Pharmacol Physiol 2004; 31(11):828–832.PubMedCrossRefGoogle Scholar
  12. 12.
    Bathgate RA, Ivell R, Sanborn BM et al. International Union of Pharmacology LVII: recommendations for the nomenclature of receptors for relaxin family peptides. Pharmacol Rev 2006; 58(1):7–31.PubMedCrossRefGoogle Scholar
  13. 13.
    Dessauer CW, Nguyen BT. Relaxin stimulates multiple signaling pathways: activation of cAMP, PI3K and PKCzeta in THP-1 cells. Ann NY Acad Sci 2005; 1041:272–279.PubMedCrossRefGoogle Scholar
  14. 14.
    Nguyen BT, Dessauer CW. Relaxin stimulates protein kinase C zeta translocation: requirement for cyclic adenosine 3′,5′-monophosphate production. Mol Endocrinol 2005; 19(4):1012–1023.PubMedCrossRefGoogle Scholar
  15. 15.
    Kuenzi MJ, Connolly BA, Sherwood OD. Relaxin acts directly on rat mammary nipples to stimulate their growth. Endocrinology 1995; 136(7):2943–2947.PubMedCrossRefGoogle Scholar
  16. 16.
    Min G, Sherwood OD. Identification of specific relaxin-binding cells in the cervix, mammary glands, nipples, small intestine and skin of pregnant pigs. Biol Reprod 1996; 55:1243–1252.PubMedCrossRefGoogle Scholar
  17. 17.
    Mercado-Simmen RC, Bryant-Greenwood GD, Greenwood FC. Characterization of the binding of 125I-relaxin to rat uterus. J Biol Chem 1980; 225:3617–3623.Google Scholar
  18. 18.
    Mercado-Simmen RC, Bryant-Greenwood GD, Greenwood FC. Relaxin receptor in the rat myometrium: regulation by estrogen and relaxin. Endocrinology 1982; 110(1):220–226.PubMedGoogle Scholar
  19. 19.
    Tan YY, Wade JD, Tregear GW et al. Quantitative autoradiographic studies of relaxin binding in rat atria, uterus and cerebral cortex: characterization and effects of oestrogen treatment. Br J Pharmacol 1999; 127(1):91–98.PubMedCrossRefGoogle Scholar
  20. 20.
    Hsu SY, Kudo M, Chen T et al. The three subfamilies of leucine-rich repeat-containing G protein-coupled receptors (LGR): identification of LGR6 and LGR7 and the signalling mechanism for LGR7. Mol Endocrinol 2000; 14(8):1257–1271.PubMedCrossRefGoogle Scholar
  21. 21.
    Krajnc-Franken MAM, van Disseldorp JM, Koenders JE et al. Impaired nipple development and parturition in LGR7 knockout mice. Mol Cell Biol 2004; 24(2):687–696.PubMedCrossRefGoogle Scholar
  22. 22.
    Feng S, Bogatcheva NV, Kamat AA et al. Endocrine effects of relaxin overexpression in mice. Endocrinology 2006; 147(1):407–414.PubMedCrossRefGoogle Scholar
  23. 23.
    Siebel AL, Gehring HM, Reytomas IGT et al. Inhibition of oxytocin receptor and estrogen receptor-α, but not relaxin receptors (LGR7), in the myometrium of late pregnant relaxin gene knockout mice. Endocrinology 2003; 144(10):4272–4275.PubMedCrossRefGoogle Scholar
  24. 24.
    Siebel AL, Gehring HM, Vodstrcil L et al. Oxytocin and estrogen receptor expression in the myometrium of pregnant relaxin-deficient (Rlx-/-) mice. Ann NY Acad Sci 2005; 1041:104–109.PubMedCrossRefGoogle Scholar
  25. 25.
    Kohsaka T, Min G, Lukas G et al. Identification of specific relaxin-binding cells in the human female. Biol Reprod 1998; 59:991–999.PubMedCrossRefGoogle Scholar
  26. 26.
    Ivell R, Balvers M, Pohnke Y et al. Immunoexpression of the relaxin receptor LGR7 in breast and uterine tissues of humans and primates. Reprod Biol Endocrinol 2003; 1:114–126.PubMedCrossRefGoogle Scholar
  27. 27.
    Luna JJ, Riesewijk A, Horcajadas JA et al. Gene expression pattern and immunoreactive protein localization of LGR7 receptor in human endometrium throughout the menstrual cycle. Mol Hum Reprod 2004; 10(2):85–90.PubMedCrossRefGoogle Scholar
  28. 28.
    Bond CP, Parry LJ, Samuel CS et al. Increased expression of the relaxin receptor (LGR7) in human endometrium during the secretory phase of the menstrual cycle. J Clin Endocr Metab 2004; 89(7):3477–3485.PubMedCrossRefGoogle Scholar
  29. 29.
    Mazella J, Tang M, Tseng L. Disparate effects of relaxin and TGF beta1: relaxin increases, but TGF beta1 inhibits, the relaxin receptor and the production of IGFBP-1 in human endometrial stromal/decidual cells. Hum Reprod 2004; 19(7):1513–1518.PubMedCrossRefGoogle Scholar
  30. 30.
    Einspanier A, Muller D, Lubberstedt J et al. Characterization of relaxin binding in the uterus of the marmoset monkey. Mol Hum Reprod 2001; 7(10):963–970.PubMedCrossRefGoogle Scholar
  31. 31.
    Lowndes K, Amano A, Yamamoto SY et al. The human relaxin receptor (LGR7): expression in the fetal membranes and placenta. Placenta 2006; 27(6–7):610–618.PubMedCrossRefGoogle Scholar
  32. 32.
    Scott DJ, Layfield S, Yan Y et al. Characterization of novel splice variants of LGR7 and LGR8 reveals that receptor signaling is mediated by their unique low density lipoprotein class A modules. J Biol Chem 2006; 281(46):34942–34954.PubMedCrossRefGoogle Scholar
  33. 33.
    Sherwood OD. Multiple physiological effects of relaxin during pregnancy. In: Bazer FW, ed. The Endocrinology of Pregnancy. Totowa, New Jersey: Human Press Inc.; 1998:431–460.Google Scholar
  34. 34.
    Sherwood OD, Zhao S. Effects of relaxin on the cervix and vagina in the rat. In: Tregear GW, Ivell R, Bathgate RA, Wade JD, eds. Relaxin 2000. Dordrecht, The Netherlands: Kluwer Acadmic Publishers; 2001:53–58.Google Scholar
  35. 35.
    Parry LJ, McGuane JT, Gehring HM et al. Mechanisms of relaxin action in the reproductive tract: studies in the relaxin-deficient (Rlx-/-) mouse. Ann N Y Acad Sci 2005; 1041:91–103.PubMedCrossRefGoogle Scholar
  36. 36.
    Downing SJ, Sherwood OD. The physiological role of relaxin in the pregnant rat. IV. The influence of relaxin on cervical collagen and glycosaminoglycans. Endocrinology 1986; 118(2):471–479.PubMedGoogle Scholar
  37. 37.
    O’Day MB, Winn RJ, Easter RA et al. Hormonal control of the cervix in pregnant gilts. II. Relaxin promotes changes in the physical properties of the cervix in ovariectomized hormone-treated pregnant gilts. Endocrinology 1989; 125(6):3004–3010.PubMedGoogle Scholar
  38. 38.
    O’Day-Bowman MB, Winn RJ, Dziuk PJ et al. Hormonal control of the cervix in pregnant gilts. III. Relaxin’s influence on cervical biochemical properties in ovariectomized hormone-treated pregnant gilts. Endocrinology 1991; 129(4):1967–1976.PubMedGoogle Scholar
  39. 39.
    Zhao L, Samuel CS, Tregear GW et al. Collagen studies in late pregnant relaxin null mice. Biol Reprod 2000; 63:697–703.PubMedCrossRefGoogle Scholar
  40. 40.
    Mushayandebvu TI, Rajabi MR. Relaxin stimulates interstitial collagenase activity in cultured uterine cervical cells from nonpregnant and pregnant but not immature guinea pigs; estradiol-17 beta restores relaxin’s effect in immature cervical cells. Biol Reprod 1995; 53(5):1030–1037.PubMedCrossRefGoogle Scholar
  41. 41.
    Palejwala S, Stein DE, Weiss G et al. Relaxin positively regulates matrix metalloproteinase expression in human lower uterine segment fibroblasts using a tyrosine kinase signaling pathway. Endocrinology 2001; 142(8):3405–3413.PubMedCrossRefGoogle Scholar
  42. 42.
    Hwang JJ, Macinga D, Rorke EA. Relaxin modulates human cervical stromal cell activity. J Clin Endocrinol Metab 1996; 81(9):3379–3384.PubMedCrossRefGoogle Scholar
  43. 43.
    Lenhart JA, Ryan PL, Ohleth KM et al. Relaxin increases secretion of matrix metalloproteinase-2 and matrix metalloproteinase-9 during uterine and cervical growth and remodeling in the pig. Endocrinology 2001; 142(9):3941–3949.PubMedCrossRefGoogle Scholar
  44. 44.
    Goldsmith LT, Weiss G, Palejwala S et al. Relaxin regulation of endometrial structure and function in the rhesus monkey. Proc Natl Acad Sci USA 2004; 101(13):4685–4689.PubMedCrossRefGoogle Scholar
  45. 45.
    Mookerjee I, Unemori EN, Du XJ et al. Relaxin modulates fibroblast function, collagen production and matrix metalloproteinase-2 expression by cardiac fibroblasts. Ann N Y Acad Sci 2005; 1041:190–193.PubMedCrossRefGoogle Scholar
  46. 46.
    Samuel CS. Relaxin: antifibrotic properties and effects in models of disease. Clin Med Res 2005; 3(4):241–249.PubMedGoogle Scholar
  47. 47.
    Silvertown JD, Walia JS, Summerlee AJ et al. Functional expression of mouse relaxin and mouse relaxin-3 in the lung from an Ebola virus glycoprotein-pseudotyped lentivirus via tracheal delivery. Endocrinology 2006; 147(8):3797–3808.PubMedCrossRefGoogle Scholar
  48. 48.
    Jeyabalan A, Novak J, Danielson LA et al. Essential role for vascular gelatinase activity in relaxin-induced renal vasodilation, hyperfiltration and reduced myogenic reactivity of small arteries. Circulation Research 2003; 93:1249–1257.PubMedCrossRefGoogle Scholar
  49. 49.
    Jeyabalan A, Kerchner LJ, Fisher MC et al. Matrix metalloproteinase-2 activity, protein, mRNA and tissue inhibitors in small arteries from pregnant and relaxin-treated nonpregnant rats. J Appl Physiol 2006; 100(6):1955–1963.PubMedCrossRefGoogle Scholar
  50. 50.
    Lenhart JA, Ryan PL, Ohleth KM et al. Relaxin increases secretion of tissue inhibitor of matrix metalloproteinase-1 and-2 during uterine and cervical growth and remodeling in the pig. Endocrinology 2002; 143(1):91–98.PubMedCrossRefGoogle Scholar
  51. 51.
    Burger LL, Sherwood OD. Evidence that cellular proliferation contributes to relaxin-induced growth of both the vagina and the cervix in the pregnant rat. Endocrinology 1995; 136(11):4820–4826.PubMedCrossRefGoogle Scholar
  52. 52.
    Ramos JG, Varayoud J, Bosquiazzo VL et al. Cellular turnover in the rat uterine cervix and its relationship to estrogen and progesterone receptor dynamics. Biol Reprod 2002; 67:735–742.PubMedCrossRefGoogle Scholar
  53. 53.
    Lee HY, Zhao S, Fields PA et al. The extent to which relaxin promotes proliferation and inhibits apoptosis of cervical epithelial and stromal cells is greatest during late pregnancy in rats. Endocrinology 2005; 146(1):511–518.PubMedCrossRefGoogle Scholar
  54. 54.
    Burger LL, Sherwood OD. Relaxin increases the accumulation of new epithelial and stromal cells in the rat cervix during the second half of pregnancy. Endocrinology 1998; 139(9):3984–3995.PubMedCrossRefGoogle Scholar
  55. 55.
    Zhao S, Fields PA, Sherwood OD. Evidence that relaxin inhibits apoptosis in the cervix and the vagina during the second half of pregnancy in the rat. Endocrinology 2001; 142(6):2221–2229.PubMedCrossRefGoogle Scholar
  56. 56.
    Zhao S, Kuenzi M, Sherwood O. Monoclonal antibodies specific for rat relaxin. IX. Evidence that endogenous relaxin promotes growth of the vagina during the second half of pregnancy in rats. Endocrinology 1996; 137(2):425–430.PubMedCrossRefGoogle Scholar
  57. 57.
    Johnson MR, Abdalla H, Allman AC et al. Relaxin levels in ovum donation pregnancies. Fertil Steril 1991; 56(1):59–61.PubMedGoogle Scholar
  58. 58.
    Relaxin and related peptides. New York: New York Academy of Sciences; 2005.Google Scholar
  59. 59.
    Steinetz BG, Beach VL, Blye RP et al. Changes in the composition of the rat uterus following a single injection of relaxin. Endocrinology 1957; 61:287–292.PubMedGoogle Scholar
  60. 60.
    Brennan DM, Zarrow MX. Water and electrolyte content of the uterus of the intact and adrenalectomized rat treated with relaxin and various steroid hormones. Endocrinology 1959; 64:907–913.Google Scholar
  61. 61.
    Vasilenko P, Mead JP, Weidmann JE. Uterine growth-promoting effects of relaxin: a morphometric and histological analysis. Biol Reprod 1986; 35:987–995.PubMedCrossRefGoogle Scholar
  62. 62.
    Pillai SB, Rockwell C, Sherwood OD et al. Relaxin stimulates uterine edema via activation of estrogen receptors: blockade of its effects using ICI 182, 780, a specific estrogen receptor antagonist. Endocrinology 1999; 140(5):2426–2429.PubMedCrossRefGoogle Scholar
  63. 63.
    Hall JA, Cantley TC, Day BN et al. Uterotropic actions of relaxin in prepubertal gilts. Biol Reprod 1990; 42(5–6):769–774.PubMedCrossRefGoogle Scholar
  64. 64.
    Bagnell CA, Zhang Q, Downey B et al. Sources and biological actions of relaxin in pigs. J Reprod Fertil 1993;48:127–138.Google Scholar
  65. 65.
    Bagnell CA, Yan W, Wiley AA et al. Effects of relaxin on neonatal porcine uterine growth and development. Ann N Y Acad Sci 2005; 1041:248–255.PubMedCrossRefGoogle Scholar
  66. 66.
    Ohleth KM, Lenhart JA, Ryan PL et al. Relaxin increases insulin-like growth factors (IGFs) and IGF-binding proteins of the pig uterus in vivo. Endocrinology 1997; 138(9):3652–3658.PubMedCrossRefGoogle Scholar
  67. 67.
    Ohleth KM, Zhang Q, Lenhart JA et al. Trophic effects of relaxin on reproductive tissus: role of the IGF system. Steroids 1999; 64(9):634–639.PubMedCrossRefGoogle Scholar
  68. 68.
    Lenhart JA, Ryan PL, Ohleth KM et al. Expression of connexin-26,-32 and-43 gap junction proteins in the porcine cervix and uterus during pregnancy and relaxin-induced growth. Biol Reprod 1999; 61:1452–1459.PubMedCrossRefGoogle Scholar
  69. 69.
    Ryan PL, Baum DL, Lenhart JA et al. Expression of uterine and cervical epithelial cadherin during relaxin-induced growth in pigs. Reproduction 2001; 122(6):929–937.PubMedCrossRefGoogle Scholar
  70. 70.
    Brody S, Wiqvist N. Ovarian hormones and uterine growth: effects of estradiol, progesterone and relaxin on cell growth and cell division in the rat uterus. Endocrinology 1961; 68:971–977.Google Scholar
  71. 71.
    Pillai SB, Jones JM, Koos RD. Treatment of rats with 17 beta-estradiol or relaxin rapidly inhibits uterine estrogen receptor beta1 and beta2 messenger ribonucleic acid levels. Biol Reprod 2002; 67:1919–1926.PubMedCrossRefGoogle Scholar
  72. 72.
    Hall JM, McDonnell DP. The estrogen receptor beta-isoform (ERbeta) of the human estrogen receptor modulates ERalpha transcriptional activity and is a key regulator of the cellular response to estrogens and antiestrogens. Endocrinology 1999; 140:5566–5578.PubMedCrossRefGoogle Scholar
  73. 73.
    Lindberg MK, Moverare S, Skrtic S et al. Estrogen receptor (ER)-beta reduces ERalpha-regulated gene transcription, supporting a “ying yang” relationship between ERalpha and ERbeta in mice. Mol Endocrinol 2003; 17:203–208.PubMedCrossRefGoogle Scholar
  74. 74.
    Huang JR, Tseng L, Bischof P et al. Regulation of prolactin production by progestin, estrogen and relaxin in human endometrial stromal cells. Endocrinology 1987; 121(6):2011–2017.PubMedCrossRefGoogle Scholar
  75. 75.
    Zhu HH, Huang JR, Mazella J et al. Differential effects of progestin and relaxin on the synthesis and secretion of immunoreactive prolactin in long term culture of human endometrial stromal cells. J Clin Endocrinol Metab 1990; 71(4):889–899.PubMedGoogle Scholar
  76. 76.
    Tseng L, Gao JG, Chen R et al. Effect of progestin, antiprogestin and relaxin on the accumulation of prolactin and insulin-like growth factor-binding protein-1 messenger ribonucleic acid in human endometrial stromal cells. Biol Reprod 1992; 47(3):441–450.PubMedCrossRefGoogle Scholar
  77. 77.
    Dimitriadis E, Stoikos C, Baca M et al. Relaxin and prostaglandin E(2) regulate interleukin 11 during human endometrial stromal cell decidualization. J Clin Endocrinol Metab 2005; 90(6):3458–3465.PubMedCrossRefGoogle Scholar
  78. 78.
    Tang M, Mazella J, Zhu HH et al. Ligand activated relaxin receptor increases the transcription of IGFBP-1 and prolactin in human decidual and endometrial stromal cells. Mol Hum Reprod 2005; 11(4):237–243.PubMedCrossRefGoogle Scholar
  79. 79.
    Pohnke Y, Kempf R, Gellcrscn B. CCAAT/enhancer-binding proteins arc mediators in the protein kinase A-dependent activation of the decidual prolactin promoter. J Biol Chem 1999; 274(35):24808–24818.PubMedCrossRefGoogle Scholar
  80. 80.
    Millar LK, Reiny R, Yamamoto SY et al. Relaxin causes proliferation of human amniotic epithelium by stimulation of insulin-like growth factor-II. Am J Obstet Gynecol 2003; 188(1):234–241.PubMedCrossRefGoogle Scholar
  81. 81.
    Jauniaux E, Johnson MR, Jurkovic D et al. The role of relaxin in the development of the uteroplacental circulation in early pregnancy. Obstet Gynecol 1994; 84(3):339–342.Google Scholar
  82. 82.
    Unemori EN, Erikson ME, Rocco SE et al. Relaxin stimulates expression of vascular endothelial growth factor in normal human endometrial cells in vitro and is associated with menometrorrhagia in women. Hum Reprod 1999; 14(3):800–806.PubMedCrossRefGoogle Scholar
  83. 83.
    Palejwala S, Tseng L, Wojtczuk A et al. Relaxin gene and protein expression and its regulation of procollagenase and vascular endothelial growth factor in human endometrial cells. Biol Reprod 2002; 66:1743–1748.PubMedCrossRefGoogle Scholar
  84. 84.
    Koos RD, Kazi AA, Roberson MS, Jones JM. New insight into the transcriptional regulation of vascular endothelial growth factor expression in the endometrium by estrogen and relaxin. Ann N Y Acad Sci 2005; 1041:233–247.PubMedCrossRefGoogle Scholar
  85. 85.
    Silvertown JD, Ng J, Sato T et al. H2 relaxin overexpression increases in vivo prostate xenograft tumor growth and angiogenesis. Int J Cancer 2006; 118(1):62–73.PubMedCrossRefGoogle Scholar
  86. 86.
    Hisaw FL, Hisaw FL, Jr., Dawson AB. Effects of relaxin on the endothelium of endometrial blood vessels in monkeys (Macaca mulatta). Endocrinology 1967; 81(2):375–385.PubMedGoogle Scholar
  87. 87.
    Dallenbach-Hellweg G, Battista JV, Dallenbach FD. Immunohistological and histochemical localization of relaxin in the metrial gland of the pregnant rat. Am J Anat 1965; 117(3):433–450.PubMedCrossRefGoogle Scholar
  88. 88.
    Einspanier A. Relaxin is an important factor for uterine differentiation and implantation in the marmoset monkey. In: Tregear GW, Ivell R, Bathgate RA, Wade JD, eds. Relaxin 2000. Dordrecht, The Netherlands: Kluwer Academic Publishers; 2001:73–82.Google Scholar
  89. 89.
    Seibold JR, Korn JH, Simms R et al. Recombinant human relaxin in the treatment of scleroderma. A randomized, double-blind, placebo-controlled trial. Ann Intern Med 2000; 132(11):871–879.PubMedGoogle Scholar
  90. 90.
    Longo M, Jain V, Vedernikov YP et al. Effects of recombinant human relaxin on pregnant rat uterine artery and myometrium in vitro. Am J Obstet Gynecol 2003; 188(6):1468–1476.PubMedCrossRefGoogle Scholar
  91. 91.
    Novak J. Relaxin increases uterine blood flow in concious nonpregnant rats and decreases myogenic reactivity in isolated uterine arteries. FASEB. 2002; 16:A824.Google Scholar
  92. 92.
    Min G, Hartzog MG, Jennings RL et al. Evidence that endogenous relaxin promotes growth of the vagina and uterus during pregnancy in gilts. Endocrinology 1997; 138(2):560–565.PubMedCrossRefGoogle Scholar
  93. 93.
    Conrad KP, Parry LJ, Shroff SG et al. Evidence that relaxin is a vascular-derived, locally-acting relaxing and compliance factor. J Soc Gynecol Invest 2005; 12:Suppl:688A.Google Scholar
  94. 94.
    Sakbun V, Ali SM, Greenwood FC et al. Human relaxin in the amnion, chorion, decidua parietalis, basal plate and placental trophoblast by immunocytochemistry and northern analysis. J Clin Endocrinol Metab 1990; 70(2):508–514.PubMedGoogle Scholar
  95. 95.
    Liu HC, Mele CA, Noyes N et al. Endometrial secretory proteins enhance early embryo development. J Assist Reprod Genet 1994; 11(4):217–224.PubMedCrossRefGoogle Scholar
  96. 96.
    Heinonen S, Taipale P, Saarikoski S. Weights of placentae from small-for-gestational age infants revisited. Placenta 2001; 22:399–404.PubMedCrossRefGoogle Scholar
  97. 97.
    Stewart DR, Addiego LA, Pascoe DR et al. Breed differences in circulating equine relaxin. Biol Reprod 1992; 46(4):648–652.PubMedCrossRefGoogle Scholar
  98. 98.
    Ryan PL, Vaala W, Bagnell CA. Evidence that equine relaxin is a good indicator of placental insufficiency in the mare. Paper presented at: Proceedings 44th Annual Convention of American Association of Equine Practitioners, 1998.Google Scholar
  99. 99.
    Ryan P, Vaala W, Bennett-Wimbush K et al. Relaxin and placental dysfunction in the horse. In: Tregear GW, Ivell R, Bathgate RA, Wade JD, eds. Relaxin 2000. Dordrecht, The Netherlands: Kluwer Academic Publishers; 2001:91–99.Google Scholar
  100. 100.
    Pillai SB, Sherwood OD, Koos RD. Relaxin up-regulates rat uterine vascular endothelial growth factor mRNA in vivo. In: Tregear GW, Ivell R, Bathgate RA, Wade JD, eds. Relaxin 2000. Dordrecht, The Netherlands: Kluwer Academic Publishers; 2001:109–113.Google Scholar

Copyright information

© Landes Bioscience and Springer Science+Business Media 2007

Authors and Affiliations

  1. 1.Department of ZoologyUniversity of MelbourneParkvilleAustralia

Personalised recommendations